Specific Biologic Effects of Intestinal Glucagon-Like Materials
AUTOR(ES)
Gutman, Raul A.
RESUMO
It has been demonstrated that gastrointestinal extracts contain substances which react immunologically with antibodies prepared to pancreatic glucagon. These extracts have been termed intestinal GLI for glucagon-like immunoreactivity, or enteroglucagon. To determine whether GLI has specific biological effects, studies were designed using the criterion of effect with antiglucagon antibodies. These antibodies did not cross-react with either secretin or pancreozymin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=302372Documentos Relacionados
- Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
- The Effects of Triglyceride Absorption upon Glucagon, Insulin, and Gut Glucagon-Like Immunoreactivity
- The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
- Glucagon-like peptide 1 (1–37) converts intestinal epithelial cells into insulin-producing cells
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
